Gene-programmed micro-nano metabolic engine drives coupled osteogenic-angiogenic regeneration.
Wu Yang1, Tao Ding2, Yu Zhang1
1Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, PR China; Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, Turku, 20520, Finland.
This study introduces a novel metabolic engine to enhance bone healing by restoring nitric oxide (NO) production in bone defects. The engineered system boosts osteogenic and angiogenic signaling for improved bone regeneration.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Cell Biology
Background:
- Effective bone healing relies on coupled osteogenic-angiogenic regeneration, dependent on metabolic communication between mesenchymal stem cells and endothelial cells.
- Nitric oxide (NO) produced by endothelial nitric oxide synthase (eNOS) is crucial for this process, but its synthesis is impaired in hypoxic bone defects.
- Hypoxia restricts eNOS expression and depletes its substrate, l-arginine, hindering NO biosynthesis and subsequent tissue regeneration.
Purpose of the Study:
- To develop a gene-programmed micro-nano metabolic engine (GP-MNME) for reconstructing NO metabolic homeostasis in bone defects.
- To enhance the synergistic coupling of osteogenic and angiogenic signaling pathways for improved bone regeneration.
- To address the limitations of hypoxic microenvironments in large bone defects by proactively modulating cellular metabolism.
Main Methods:
- Fabrication of a dual-module GP-MNME: a nano-module with l-arginine-modified nanoparticles for BMP-2 mRNA delivery and a micro-module of GelMA microgels for BMSC targeting and nano-module encapsulation.
- In situ delivery of GP-MNME to bone defects to enrich BMSCs and release nano-modules.
- Evaluation of GP-MNME's effect on eNOS expression, l-arginine supply, NO production, osteogenic mineralization, and angiogenic sprouting.
Main Results:
- GP-MNME successfully upregulated eNOS expression and supplied l-arginine, leading to a synergistic increase in NO production (>3.1-fold).
- Re-established NO homeostasis promoted osteogenic mineralization and angiogenic sprouting (both >3-fold).
- Significant promotion of coupled osteogenic-angiogenic regeneration in rat bone defects, evidenced by increased new bone formation (>2.4-fold).
Conclusions:
- The developed GP-MNME effectively reconstructs intracellular NO biosynthesis in situ, presenting a proactive metabolic modulation strategy for bone regeneration.
- This approach overcomes the challenges posed by hypoxic microenvironments in large bone defects.
- The study demonstrates the potential of engineered metabolic engines for enhancing coupled osteogenic-angiogenic regeneration.
More Related Videos
08:28A Lab-On-A-Chip Platform for Stimulating Osteocyte Mechanotransduction and Analyzing Functional Outcomes of Bone Remodeling
Published on: May 21, 2020
10:45Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling
Published on: May 31, 2017
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Bone Remodeling and Repair
Whole Body Regeneration
